Holen Sie sich die Stockscreener-App
1.36
2.26%
0.03
Nyxoah Sa Aktie (NYXH) Neueste Nachrichten
Nyxoah (NASDAQ: NYXH) Stock Price, News & Analysis - Kalkine
With Genio approved by the FDA and launched in the U.S., Nyxoah (NYXH) names a new CEO - Stock Titan
Nyxoah Appoints New CEO to Drive US Expansion - Sleep Review
Discontinued operations of Nyxoah SA – HAN:5YI - TradingView
Nyxoah names Liam Kelly as CEO - Medical Buyer
Nyxoah SA Announces CEO Changes, Effective October 1, 2026 - marketscreener.com
A former medical-device CEO will lead Nyxoah while its U.S. launch is still in early stages. - Stock Titan
Nyxoah Appoints Liam Kelly as Chief Executive Officer - GlobeNewswire
Nyxoah Names Former CFO Loïc Moreau as Interim Finance Chief, Reaffirms 2026 Guidance - The Globe and Mail
CFO John Landry to leave Nyxoah (NASDAQ: NYXH) in 2026 as company searches for his successor - Stock Titan
NYXH.BB Price History for Nyxoah Sa Stock - Barchart.com
Nyxoah shares fall after CFO departure announcement - Investing.com
Nyxoah shares fall after CFO departure announcement By Investing.com - Investing.com Australia
Nyxoah announces CFO transition, reaffirms 2026 guidance By Investing.com - Investing.com India
Nyxoah announces CFO transition, reaffirms 2026 guidance - Investing.com
A medical technology company expects €36M–€40M in 2026 revenue. Nyxoah’s finance chief is set to leave. - Stock Titan
Nyxoah Announces Chief Financial Officer Transition - Finansavisen
Nyxoah SA(ENXTBR: NYXH) dropped from S&P Global BMI Index - marketscreener.com
Cantor Fitzgerald reiterates Nyxoah stock Overweight rating at $6 By Investing.com - Investing.com South Africa
Nyxoah (NYXH) Begins BREATHE Study. Can Real-World Evidence Drive Genio Adoption? - Yahoo Finance
Nyxoah SA Actuals & Estimates (HAM:5YI) - TradingView
Gross profit of Nyxoah SA – HAM:5YI - TradingView
Price to book ratio of Nyxoah SA – HAM:5YI - TradingView
Nyxoah Begins U.S. Post-Approval Study of Genio Sleep Apnea Implant - finance.biggo.com
Cash per share of Nyxoah SA – HAM:5YI - TradingView
Nyxoah Stock Down Despite First Genio Implant in U.S. BREATHE Trial - Yahoo Finance
Nyxoah implants first patient in BREATHE study of Genio - Yahoo
symbol__ Stock Quote Price and Forecast - CNN
Nyxoah Launches Major U.S. Post-Approval Study for Genio Sleep Apnea Device - TipRanks
Nyxoah Announces First Patient Implanted in BREATHE, the U.S. Post-Approval Study of the Genio® System - GlobeNewswire
The trading volume of these stocks is deviating from the norm in today's session. - ChartMill
Nyxoah SA (NYXH) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Cantor Fitzgerald reiterates Nyxoah stock rating on trial success By Investing.com - Investing.com Canada
Cantor Fitzgerald reiterates Nyxoah stock rating on trial success - Investing.com
Nyxoah stock rises on pivotal trial win for Genio (NYXH:NASDAQ) - Seeking Alpha
Nyxoah stock surges as sleep apnea study hits endpoints By Investing.com - Investing.com India
NYXH Jumps As ACCCESS Trial Data Reset The Trading Map - timothysykes.com
NYXH Stock Jumps As ACCCESS Trial De‑Risks Sleep Apnea Bet - StocksToTrade
NYXH Stock Pops As ACCCESS Trial Data Fuels Breakout Hopes - timothysykes.com
NYXH Stock Jumps As ACCCESS Trial De-Risks U.S. Growth Story - StocksToTrade
Nyxoah stock surges as sleep apnea study hits endpoints - Investing.com
87.7% improved on a measure of oxygen drops during sleep. No device-related serious adverse events were reported. - Stock Titan
Nyxoah Announces ACCCESS U.S. Pivotal Study Meets Primary - GlobeNewswire
Nyxoah SA (NYXH) Stock Price & News - Syfe
Information on the total number of voting rights and shares - Finansavisen
Nyxoah (NYXH) Results Versus Estimates: The Available Earnings Metric Delivers a Miss in the Current Update; Market Reaction: The Share Price Sheds 2.74% in the Current UpdateEarnings Power Value - vinanet.vn
Nyxoah (NYXH) Latest: Falls 2.74% to $1.60 in Latest Trading; Price Context: the Current Price Sits Inside the Supplied Technical Range at the CloseIndex Put Call - vinanet.vn
Cantor Fitzgerald cuts Nyxoah stock price target on valuation By Investing.com - Investing.com Nigeria
Cantor Fitzgerald cuts Nyxoah stock price target on valuation - Investing.com
Cantor Fitzgerald Issues Pessimistic Forecast for Nyxoah (NASDAQ:NYXH) Stock Price - MarketBeat
NYXH Q2 2026 Earnings: EPS Miss of 46.48% Overshadowed by 2.53% Share GainCapex Guidance - vinanet.vn
2.06%
0.87%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):